| An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ... New England Journal of Medicine 360 (23), 2426-2437, 2009 | 1038 | 2009 |
| Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease EF Remmers, F Cosan, Y Kirino, MJ Ombrello, N Abaci, C Satorius, JM Le, ... Nature genetics 42 (8), 698-702, 2010 | 759 | 2010 |
| Common variants at CD40 and other loci confer risk of rheumatoid arthritis S Raychaudhuri, EF Remmers, AT Lee, R Hackett, C Guiducci, NP Burtt, ... Nature genetics 40 (10), 1216-1223, 2008 | 611 | 2008 |
| Myofibroblasts in murine cutaneous fibrosis originate from adiponectin‐positive intradermal progenitors RG Marangoni, BD Korman, J Wei, TA Wood, LV Graham, ML Whitfield, ... Arthritis & rheumatology 67 (4), 1062-1073, 2015 | 323 | 2015 |
| Variant form of STAT4 is associated with primary Sjögren's syndrome BD Korman, MI Alba, JM Le, I Alevizos, JA Smith, NP Nikolov, DL Kastner, ... Genes & Immunity 9 (3), 267-270, 2008 | 204 | 2008 |
| STAT4: genetics, mechanisms, and implications for autoimmunity BD Korman, DL Kastner, PK Gregersen, EF Remmers Current allergy and asthma reports 8 (5), 398-403, 2008 | 198 | 2008 |
| Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations HS Lee, BD Korman, JM Le, DL Kastner, EF Remmers, PK Gregersen, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 149 | 2009 |
| Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States SRS Parker, S Dyson, S Brisman, M Pennie, RA Swerlick, R Khan, ... Journal of the American Academy of Dermatology 59 (4), 582-588, 2008 | 123 | 2008 |
| Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists BD Korman, KL Tyler, NJ Korman Archives of dermatology 145 (8), 937-942, 2009 | 91 | 2009 |
| Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis B Korman Translational Research 209, 77-89, 2019 | 85 | 2019 |
| Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target RG Marangoni, Y Masui, F Fang, B Korman, G Lord, J Lee, K Lakota, ... Scientific reports 7 (1), 4397, 2017 | 77 | 2017 |
| HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry P Gourh, SA Safran, T Alexander, SE Boyden, ND Morgan, AA Shah, ... Proceedings of the National Academy of Sciences 117 (1), 552-562, 2020 | 61 | 2020 |
| Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance BD Korman, LA Criswell Current rheumatology reports 17, 1-11, 2015 | 40 | 2015 |
| Validation of the self‐efficacy for managing chronic disease scale: a Scleroderma Patient‐Centered Intervention Network cohort Study KE Riehm, L Kwakkenbos, ME Carrier, SJ Bartlett, VL Malcarne, ... Arthritis care & research 68 (8), 1195-1200, 2016 | 39 | 2016 |
| Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis BD Korman, CC Huang, C Skamra, P Wu, R Koessler, D Yao, QQ Huang, ... Arthritis Research & Therapy 16, 1-12, 2014 | 37 | 2014 |
| Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis B Shi, W Wang, B Korman, L Kai, Q Wang, J Wei, S Bale, RG Marangoni, ... Iscience 24 (1), 2021 | 36 | 2021 |
| Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative J Wei, H Zhu, G Lord, M Bhattachayya, BM Jones, G Allaway, SS Biswal, ... Translational Research 183, 71-86. e1, 2017 | 32 | 2017 |
| Brief report: association of elevated adipsin levels with pulmonary arterial hypertension in systemic sclerosis BD Korman, RG Marangoni, M Hinchcliff, SJ Shah, M Carns, A Hoffmann, ... Arthritis & Rheumatology 69 (10), 2062-2068, 2017 | 31 | 2017 |
| Adipocyte-specific repression of PPAR-gamma by NCoR contributes to scleroderma skin fibrosis B Korman, RG Marangoni, G Lord, J Olefsky, W Tourtellotte, J Varga Arthritis Research & Therapy 20, 1-11, 2018 | 29 | 2018 |
| Using optimal test assembly methods for shortening patient‐reported outcome measures: development and validation of the Cochin Hand Function Scale‐6: a scleroderma patient … AW Levis, D Harel, L Kwakkenbos, ME Carrier, L Mouthon, S Poiraudeau, ... Arthritis Care & Research 68 (11), 1704-1713, 2016 | 29 | 2016 |
